| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 p...
HC Wainwright & Co. analyst Andres Maldonado assumes Aura Biosciences (NASDAQ:AURA) with a Buy rating and announces Pric...
JMP Securities analyst Jonathan Wolleben reiterates Aura Biosciences (NASDAQ:AURA) with a Market Outperform and maintains $1...